Short Interest in Terumo Corp. (OTCMKTS:TRUMY) Drops By 74.5%

Terumo Corp. (OTCMKTS:TRUMY) was the recipient of a large decline in short interest during the month of June. As of June 30th, there was short interest totaling 47,370 shares, a decline of 74.5% from the June 15th total of 185,946 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily volume of 268,986 shares, the days-to-cover ratio is presently 0.2 days.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of Terumo to a “hold” rating in a research report on Thursday, April 9th. Two equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, Terumo currently has an average rating of “Hold”.

Terumo Stock Performance

Shares of Terumo stock traded down $0.14 during trading on Friday, hitting $13.59. 117,827 shares of the company’s stock traded hands, compared to its average volume of 120,095. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.59 and a quick ratio of 0.97. Terumo has a 1 year low of $12.08 and a 1 year high of $19.60. The stock has a market capitalization of $20.05 billion, a P/E ratio of 22.28 and a beta of 0.68. The business has a 50-day simple moving average of $13.81 and a 200-day simple moving average of $13.61.

Terumo (OTCMKTS:TRUMY) last released its quarterly earnings data on Friday, May 15th. The company reported $0.11 EPS for the quarter, hitting the consensus estimate of $0.11. Terumo had a return on equity of 9.17% and a net margin of 12.09%.The company had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.84 billion. As a group, analysts forecast that Terumo will post 0.7 EPS for the current year.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.